Home › Steatotische leveraandoening

Steatotische leveraandoening klinische studies rekruteren in de VS

65 studies voor Steatotische leveraandoening rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• San Antonio, TX17 studies
• New York City, NY16 studies
• Miami, FL16 studies
• San Diego, CA14 studies
• Austin, TX13 studies
• Houston, TX13 studies
• Richmond, VA12 studies
• Tucson, AZ10 studies
• Chandler, AZ10 studies
• Orlando, FL9 studies
• Hialeah, FL9 studies
• St. Louis, MO9 studies
• Dallas, TX9 studies
• Durham, NC8 studies
• Dayton, OH8 studies
• Little Rock, AR8 studies
• Los Angeles, CA8 studies
• New Orleans, LA8 studies
• Pasadena, CA8 studies
• Ocala, FL8 studies
• Rochester, MN8 studies
• Akron, OH7 studies
• Seattle, WA7 studies
• Washington, DC7 studies
• Parma, OH7 studies
• Lancaster, CA7 studies
• Brownsville, TX7 studies
• Topeka, KS7 studies
• Las Vegas, NV7 studies
• Round Rock, TX7 studies
• Chicago, IL6 studies
• Sugar Land, TX6 studies
• Cape Coral, FL6 studies
• Sarasota, FL6 studies
• Sandy Springs, GA6 studies
• Peoria, AZ6 studies
• Indianapolis, IN6 studies
• Fort Worth, TX6 studies
• Fayetteville, NC6 studies
• Arlington, TX6 studies

Per staat

• Alabama4 studies
• Arizona14 studies
• Arkansas8 studies
• Californië22 studies
• Colorado6 studies
• Connecticut5 studies
• Florida20 studies
• Georgia8 studies
• Illinois6 studies
• Indiana9 studies
• Iowa4 studies
• Kansas7 studies
• Kentucky4 studies
• Louisiana11 studies
• Maryland8 studies
• Massachusetts9 studies
• Michigan8 studies
• Minnesota9 studies
• Mississippi5 studies
• Missouri14 studies
• Nevada7 studies
• New Jersey6 studies
• New Mexico3 studies
• New York17 studies
• North Carolina13 studies
• Ohio15 studies
• Pennsylvania5 studies
• Rhode Island3 studies
• South Carolina5 studies
• Tennessee7 studies
• Texas20 studies
• Utah5 studies
• Virginia14 studies
• Washington7 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.